Skip to main content

Table 4 Response to treatment

From: Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

Response

CR

PR

S

P

Number patient (%)

9 (82%)

1 (9%)

0

1 (9%)